Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11R,14S,17S,20S,23S,26S,31S)-14,20,26-tris(4-aminobutyl)-11-((4-(3-benzoylbenzyloxy)-3-methylbut-2-enylthio)methyl)-5-sec-butyl-31-(4-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethylamino)butyl)-8-(4-(3,5-dinitrophenylamino)butyl)-17-((R)-1-hydroxyethyl)-23-(hydroxymethyl)-2-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,30,33,36,49-tridecaoxo-53-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-39,42,45,48-tetraoxa-3,6,9,12,15,18,21,24,27,29,32,37-dodecaazatripentacontan-1-oic acid
ID: ALA1253600
Chembl Id: CHEMBL1253600
PubChem CID: 52948480
Max Phase: Preclinical
Molecular Formula: C108H165N21O30S3
Molecular Weight: 2333.83
Molecule Type: Small molecule
Associated Items: